Abstract:Orphanin FQ (nociceptin, OFQ), a hepatdecapeptide peptide, has been designated as an endogenous ligand at the orphan receptor ORL1, which lacks affinity for opioid receptor ligands. OFQ-like immunoreactivity has been localized in spinal cord areas that are involved in the processing of nociceptive signals. In this study, the effects of spinally administered OFQ on thermal and mechanical nociceptive stimuli were investigated following intrathecal (i.t.) injection in unanesthetized rats bearing chronic indwelling catheters in the subarachnoid space. Intrathecal OFQ produced two distinct acute actions: an opioid-like antinociceptive effect, and antagonism of morphine-induced antinociception. Chronic administration produces tolerance. Acute actions were as follows. First, injection of OFQ alone in the dose range 10-100 nmol produced sustained antinociceptive effects in the tail-flick (baseline latency 1.5-2 s) and paw-pressure tests. These effects peaked at 45-60 min post-injection, were fully reversible, and were observed in absence of discernable motor impairments. Intrathecal naloxone (5 nmol) significantly attenuated the antinociceptive effects of OFQ (50 nmol i.t.) in tail-flick and paw-pressure tests. A 24-h pretreatment with the irreversible opioid receptor antagonist, beta-flunatrexamine (2 nmol i.t.), also attenuated the antinociceptive effects of OFQ (50, 100 nmol i.t.) and of morphine (7.5 nmol i.t.) in both tests. Low doses (1, 5 nmol) of OFQ, which failed to produce antinociception in the tail-flick test involving a baseline latency of 1.5-2 s, produced a strong antinociceptive response when the baseline latency was increased to 5-6 s. Second, intrathecal OFQ, at doses (0.5, 1.0, and 5.0 nmol) that had no antinociceptive activity in the tail-flick (baseline latency 1.5-2 s) and paw-pressure tests, attenuated the antinociceptive effect of morphine (7.5 nmol i.t.) in these tests. However, a threshold OFQ dose (10 nmol) significantly extended the duration of antinociception induced by morphine (7.5 nmol i.t.) or deltorphin (20 nmol i.t.). Chronic actions were as follows. In rats that were rendered tolerant to spinal morphine, by a continuous intrathecal infusion (7.5 nmol/h) of the agonist for 5 days, the OFQ dose-response curves for its antinociceptive effect in the tail-flick and paw-pressure tests were significantly shifted to the right. In separate experiments, repeated intrathecal injection of OFQ (50 nmol) or morphine (7.5 nmol) produced a significant decline in their antinociceptive effects. Thus, intrathecally administered OFQ produces both development of tolerance to its antinociceptive actions and cross-tolerance to the action of morphine.

Role of Nociceptin in the Modulation of Nociception in the Arcuate Nucleus of Rats

Blockade Effects of (Nphe1)nociceptin(1–13)-Nh2 on Anti-Nociception Induced by Intrathecal Administration of Nociceptin in Rats

Involvement of endogenous opioid systems in nociceptin-induced spinal antinociception in rats.

Nociceptin/orphanin FQ into the rat periaqueductal gray decreases the withdrawal latency to heat and loading, an effect reversed by (Nphe1)nociceptin(1–13)NH2

Effects of Nociceptin (13–17) in Pain Modulation at Supraspinal Level in Mice

Involvement of ORL1 receptor and ERK kinase in the orphanin FQ-induced nociception in the nucleus accumbens of rats.

Interactions of galanin and opioids in nociceptive modulation in the arcuate nucleus of hypothalamus in rats.

Involvement of Endogenous Beta-Endorphin in Antinociception in the Arcuate Nucleus of Hypothalamus in Rats with Inflammation

Antinociceptive Role of Oxytocin in the Nucleus Raphe Magnus of Rats, an Involvement of Μ-Opioid Receptor

Antinociceptive and morphine modulatory actions of spinal orphanin FQ

Anti-Nociceptive Role of Neuropeptide Y in the Nucleus Accumbens in Rats with Inflammation, an Effect Modulated by Mu- and Kappa-Opioid Receptors

Involvement of neuropeptide Y and Y1 receptor in antinociception in the arcuate nucleus of hypothalamus, an immunohistochemical and pharmacological study in intact rats and rats with inflammation.

Effect of Nocistatin in Pain Modulation

Involvement of Opioid Receptors in the CGRP-induced Antinociception in the Nucleus Accumbens of Rats

Role of mu-opioid receptor in nociceptive modulation in anterior cingulate cortex of rats

Nociceptin/Orphanin Fq in Pag Modulates the Release of Amino Acids, Serotonin and Norepinephrine in the Rostral Ventromedial Medulla and Spinal Cord in Rats

Involvements of Mu- and Kappa-Opioid Receptors in Morphine-Induced Antinociception in the Nucleus Accumbens of Rats

The rostral ventromedial medulla mediates the facilitatory effect of microinjected orphanin FQ in the periaqueductal gray on spinal nociceptive transmission in rats.

Progress in the Studies of Ligands for Nociceptin Receptor

Involvement of CGRP and CGRP Receptor in Nociceptive Modulation in Arcuate Nucleus of the Hypothalamus in Rats with Neuropathic Pain

Bidirectional Modulatory Effect of Orphanin Fq on Morphine-Induced Analgesia: Antagonism in Brain and Potentiation in Spinal Cord of the Rat